- Home
- APLT vs NYAX Comparison
APLT vs NYAX Comparison
Compare APLT & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- NYAX
- Stock Information
- Founded
- APLT 2016
- NYAX 2005
- Country
- APLT United States
- NYAX Israel
- Employees
- APLT N/A
- NYAX N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- NYAX
- Sector
- APLT Health Care
- NYAX
- Exchange
- APLT Nasdaq
- NYAX Nasdaq
- Market Cap
- APLT 63.6M
- NYAX 1.7B
- IPO Year
- APLT 2019
- NYAX N/A
- Fundamental
- Price
- APLT $0.41
- NYAX $46.16
- Analyst Decision
- APLT Buy
- NYAX Buy
- Analyst Count
- APLT 6
- NYAX 7
- Target Price
- APLT $6.10
- NYAX $42.00
- AVG Volume (30 Days)
- APLT 771.9K
- NYAX 11.4K
- Earning Date
- APLT 11-06-2025
- NYAX 11-11-2025
- Dividend Yield
- APLT N/A
- NYAX N/A
- EPS Growth
- APLT N/A
- NYAX N/A
- EPS
- APLT N/A
- NYAX 0.57
- Revenue
- APLT $121,000.00
- NYAX $348,663,000.00
- Revenue This Year
- APLT N/A
- NYAX $31.84
- Revenue Next Year
- APLT $5,931.24
- NYAX $22.85
- P/E Ratio
- APLT N/A
- NYAX $81.56
- Revenue Growth
- APLT N/A
- NYAX 29.63
- 52 Week Low
- APLT $0.30
- NYAX $23.52
- 52 Week High
- APLT $10.62
- NYAX $52.46
- Technical
- Relative Strength Index (RSI)
- APLT 38.50
- NYAX 42.14
- Support Level
- APLT $0.40
- NYAX $46.33
- Resistance Level
- APLT $0.46
- NYAX $51.03
- Average True Range (ATR)
- APLT 0.03
- NYAX 1.05
- MACD
- APLT -0.01
- NYAX -0.38
- Stochastic Oscillator
- APLT 7.74
- NYAX 3.18
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About NYAX Nayax Ltd.
Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.